PXD048525 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Predictive modelling of brain metastasis development from cancer and non-invasive biomarker-based risk assessment leveraging DNA methylation signatures |
Description | Brain metastases (BM) are the most common and among the most deadly brain tumors. Currently, there are no reliable predictors of BM development from primary cancer, limiting early intervention. Here, we obtained 364 tumor/plasma samples from a large cohort of lung adenocarcinoma (LUAD) and BM patients (N=309), the most common BM source. LUAD DNA methylation signatures were evaluated to build and validate an accurate model predicting BM development from LUAD, which was integrated with clinical factors to provide comprehensive patient-specific BM risk probabilities in a nomogram. Additionally, immune and cell interaction gene sets were differentially methylated at promoters in BM versus paired primary LUAD and had aligning dysregulation in the proteome. Immune cells were differentially abundant in BM versus LUAD. Finally, liquid biomarkers identified from methylated cell-free DNA sequenced in plasma were used to generate and validate accurate classifiers for early BM detection. Overall, LUAD methylomes can be leveraged to predict and non-invasively identify BM with high precision, moving towards improved patient outcomes with personalized treatment. |
HostingRepository | PRIDE |
AnnounceDate | 2025-03-21 |
AnnouncementXML | Submission_2025-03-20_20:57:31.345.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Michael Moran |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion Lumos; Bruker Daltonics instrument model |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-01-13 20:26:00 | ID requested | |
⏵ 1 | 2025-03-20 20:57:32 | announced | |
Publication List
Zuccato JA, Mamatjan Y, Nassiri F, Ajisebutu A, Liu JC, Muazzam A, Singh O, Zhang W, Voisin M, Mirhadi S, Suppiah S, Wybenga-Groot L, Tajik A, Simpson C, Saarela O, Tsao MS, Kislinger T, Aldape KD, Moran MF, Patil V, Zadeh G, Prediction of brain metastasis development with DNA methylation signatures. Nat Med, 31(1):116-125(2025) [pubmed] |
10.1038/s41591-024-03286-y; |
Keyword List
submitter keyword: Brain metastases,Lung adenocarcinoma, DNA methylation, Proteomics, Biomarkers |
Contact List
Michael F. Moran |
contact affiliation | Professor, Department of Molecular Genetics, University of Toronto, Canada Scientific Director, SPARC BioCentre, Hospital for Sick Children (Sickkids), Toronto, Canada |
contact email | mmoran@sickkids.ca |
lab head | |
Michael Moran |
contact affiliation | The Hospital for sick children |
contact email | mmoran@sickkids.ca |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD048525 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD048525
- Label: PRIDE project
- Name: Predictive modelling of brain metastasis development from cancer and non-invasive biomarker-based risk assessment leveraging DNA methylation signatures